[A CIRCULATING ANTICOAGULANT IN SYSTEMIC LUPUS ERYTHEMATOSUS]. 1965

L USZYNSKI, and S LOPACIUK, and J BLASZCZYK

UI MeSH Term Description Entries
D007136 Immunoglobulins Multi-subunit proteins which function in IMMUNITY. They are produced by B LYMPHOCYTES from the IMMUNOGLOBULIN GENES. They are comprised of two heavy (IMMUNOGLOBULIN HEAVY CHAINS) and two light chains (IMMUNOGLOBULIN LIGHT CHAINS) with additional ancillary polypeptide chains depending on their isoforms. The variety of isoforms include monomeric or polymeric forms, and transmembrane forms (B-CELL ANTIGEN RECEPTORS) or secreted forms (ANTIBODIES). They are divided by the amino acid sequence of their heavy chains into five classes (IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M) and various subclasses. Globulins, Immune,Immune Globulin,Immune Globulins,Immunoglobulin,Globulin, Immune
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D001769 Blood The body fluid that circulates in the vascular system (BLOOD VESSELS). Whole blood includes PLASMA and BLOOD CELLS.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000925 Anticoagulants Agents that prevent BLOOD CLOTTING. Anticoagulant Agent,Anticoagulant Drug,Anticoagulant,Anticoagulant Agents,Anticoagulant Drugs,Anticoagulation Agents,Indirect Thrombin Inhibitors,Agent, Anticoagulant,Agents, Anticoagulant,Agents, Anticoagulation,Drug, Anticoagulant,Drugs, Anticoagulant,Inhibitors, Indirect Thrombin,Thrombin Inhibitors, Indirect
D013925 Thromboplastin Constituent composed of protein and phospholipid that is widely distributed in many tissues. It serves as a cofactor with factor VIIa to activate factor X in the extrinsic pathway of blood coagulation. Antigens, CD142,CD142 Antigens,Coagulation Factor III,Factor III,Tissue Factor,Tissue Thromboplastin,Blood Coagulation Factor III,Coagulin,Glomerular Procoagulant Activity,Prothrombinase,Tissue Factor Procoagulant,Urothromboplastin,Activity, Glomerular Procoagulant,Factor III, Coagulation,Procoagulant Activity, Glomerular,Procoagulant, Tissue Factor,Thromboplastin, Tissue

Related Publications

L USZYNSKI, and S LOPACIUK, and J BLASZCZYK
October 1986, The Journal of rheumatology,
L USZYNSKI, and S LOPACIUK, and J BLASZCZYK
August 1956, Acta haematologica,
L USZYNSKI, and S LOPACIUK, and J BLASZCZYK
January 1986, Acta haematologica,
L USZYNSKI, and S LOPACIUK, and J BLASZCZYK
September 1999, Journal of feline medicine and surgery,
L USZYNSKI, and S LOPACIUK, and J BLASZCZYK
August 1988, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons,
L USZYNSKI, and S LOPACIUK, and J BLASZCZYK
February 1963, Acta haematologica,
L USZYNSKI, and S LOPACIUK, and J BLASZCZYK
January 1985, Revue neurologique,
L USZYNSKI, and S LOPACIUK, and J BLASZCZYK
September 1966, Henry Ford Hospital medical journal,
L USZYNSKI, and S LOPACIUK, and J BLASZCZYK
January 1990, Annales de dermatologie et de venereologie,
L USZYNSKI, and S LOPACIUK, and J BLASZCZYK
March 1981, American journal of diseases of children (1960),
Copied contents to your clipboard!